Business Description
Accretion Pharmaceuticals Ltd
ISIN : INE0T8T01010
Total Employee Number:
105Description
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.33 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | 0.81 | |||||
Interest Coverage | 16.21 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 7.12 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 46.9 | |||||
3-Year EBITDA Growth Rate | 96 | |||||
3-Year EPS without NRI Growth Rate | 359.6 | |||||
3-Year FCF Growth Rate | -203.8 | |||||
3-Year Book Growth Rate | 145.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.61 | |||||
9-Day RSI | 56.82 | |||||
14-Day RSI | 60.02 | |||||
3-1 Month Momentum % | 100.43 | |||||
6-1 Month Momentum % | 67.02 | |||||
12-1 Month Momentum % | 100.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.91 | |||||
Quick Ratio | 1.55 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 143.44 | |||||
Days Sales Outstanding | 90.1 | |||||
Days Payable | 23.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.2 | |||||
Shareholder Yield % | -17.2 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 27.31 | |||||
Operating Margin % | 15.33 | |||||
Net Margin % | 10.79 | |||||
EBITDA Margin % | 16.89 | |||||
FCF Margin % | -25.83 | |||||
OCF Margin % | -16.31 | |||||
ROE % | 19.09 | |||||
ROA % | 14.25 | |||||
ROIC % | 16.49 | |||||
3-Year ROIIC % | 17.26 | |||||
ROC (Joel Greenblatt) % | 26.05 | |||||
ROCE % | 26.94 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.24 | |||||
PE Ratio without NRI | 17.24 | |||||
PS Ratio | 1.86 | |||||
PB Ratio | 3.16 | |||||
Price-to-Tangible-Book | 3.16 | |||||
EV-to-EBIT | 13.02 | |||||
EV-to-EBITDA | 11.97 | |||||
EV-to-Revenue | 2.02 | |||||
EV-to-FCF | -7.83 | |||||
Price-to-Graham-Number | 1.56 | |||||
| Price-to-Net-Current-Asset-Value | 4.48 | |||||
Earnings Yield (Greenblatt) % | 7.68 | |||||
FCF Yield % | -13.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Accretion Pharmaceuticals Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 896.271 | ||
| EPS (TTM) (₹) | 9.03 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 107.56 | ||
| 14-Day RSI | 60.02 | ||
| 14-Day ATR (₹) | 7.217052 | ||
| 20-Day SMA (₹) | 147.5875 | ||
| 12-1 Month Momentum % | 100.57 | ||
| 52-Week Range (₹) | 53.8 - 171.15 | ||
| Shares Outstanding (Mil) | 11.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Accretion Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Accretion Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Accretion Pharmaceuticals Ltd Frequently Asked Questions
What is Accretion Pharmaceuticals Ltd(NSE:ACCPL)'s stock price today?
The current price of NSE:ACCPL is ₹155.65. The 52 week high of NSE:ACCPL is ₹171.15 and 52 week low is ₹53.80.
When is next earnings date of Accretion Pharmaceuticals Ltd(NSE:ACCPL)?
The next earnings date of Accretion Pharmaceuticals Ltd(NSE:ACCPL) is .
Does Accretion Pharmaceuticals Ltd(NSE:ACCPL) pay dividends? If so, how much?
Accretion Pharmaceuticals Ltd(NSE:ACCPL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Accretion Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers